← Back to Bills
HR 6693118th CongressFailed / ExpiredHouse

Lung Cancer Screening and Prevention Act of 2023

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 19, 2024
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Lung Cancer Screening and Prevention Act of 2023 is a legislative proposal introduced in the 118th Congress aimed at addressing lung cancer through enhanced screening and prevention measures. The bill was referred to the House Subcommittee on Health but did not advance further and is currently classified as failed or expired. Specific provisions, funding details, and implementation strategies are not available in the provided source data.

Bottom Line

This bill sought to improve lung cancer screening and prevention but did not progress beyond initial committee referral and is now expired.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill focuses on lung cancer screening and prevention within the health policy area.
  • It was introduced in the House of Representatives during the 118th Congress.
  • The latest recorded action was referral to the Subcommittee on Health on December 17, 2024.
Who Benefits?

['Individuals at risk for lung cancer who may receive improved screening and preventive care', 'Healthcare providers involved in lung cancer screening and prevention', 'Public health agencies focused on cancer prevention and control']

Potential Concerns

['Lack of detailed information on funding and implementation mechanisms limits assessment of feasibility', 'Absence of full bill text restricts understanding of specific authority or oversight provisions', 'Potential challenges in ensuring equitable access to screening and prevention services']

Political Context

The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health but did not advance further. It is currently classified as failed or expired, indicating it did not receive sufficient legislative support or priority to move forward during the session.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['Potential increased demand on healthcare providers and facilities if screening programs were implemented', 'Possible shifts in public health resource allocation toward lung cancer prevention', 'Improved early detection could influence lung cancer mortality rates if implemented']

GovScope Watchdog Notes

Due to the absence of the full bill text and official summary, transparency is limited, making it difficult to assess the bill's detailed provisions, funding, and oversight mechanisms. The bill's failure to advance beyond subcommittee referral suggests limited legislative momentum.

Passage Likelihood: LowConfidence: 60%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready